OKYO Pharma Receives FDA Approval of IND for OK-101 in Neuropathic Corneal Pain OK-101 is the first IND clearance granted by FDA for a drug to begin clinical studies specifically to treat patients suffering with neuropathic corneal pain (NCP), a major unmet medical needThe...

OKYO Pharma Announces Custom Clearance of GMP Packaged OK-101 Drug to be Used in Phase 2 Clinical Trial for Treating Dry Eye Disease LONDON and NEW YORK, Feb. 28, 2023 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (LSE: OKYO; NASDAQ: OKYO), an ophthalmology-focused bio-pharmaceutical company which is developing OK-101 to treat dry eye...

FDA Clears the Smallest Life-Saving Bleeding Control Device, COBRA-OS™, by Front Line Medical Technologies LONDON, Ontario, June 29, 2021 (GLOBE NEWSWIRE) -- Front Line Medical Technologies, Inc. announced today that the U.S. Food and Drug Administration (FDA) has cleared its COBRA-OS™ (Control of...

Biotricity Files for FDA 510(k) REDWOOD CITY, Calif., June 20, 2016 (GLOBE NEWSWIRE) -- Biotricity, Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company dedicated to delivering innovative,...

Dynamic Systems and Cyberspace Solutions Partner to Bring Technology to Intelligence Agencies Fighting the War on Terror LOS ANGELES, CA--(Marketwire - January 27, 2010) - Dynamic Systems, a leading IT solutions provider, today announced a strategic partnership with Cyberspace Solutions, an integration specialist in...